Furthermore, phospho-eIF4E plays an important role in bladder cancer progression, and targeting its upstream kinases could be an effective therapeutic option for bladder cancer patients with elevated phospho-eIF4E. The gene discussed is EIF4E; the disease is urinary bladder cancer.